FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions refers to medicine and concerns: a therapeutic agent for treating the lower urinary tract disease, wherein the agent contains a thrombin-like enzyme as a single main active ingredient; an agent for relieving the lower urinary tract pain associated with the lower urinary tract disease; a method of the treating lower urinary tract disease involving the stage of administering an effective amount of the thrombin-like enzyme.
EFFECT: group of inventions provides marginal therapeutic effects on the lower urinary tract disease.
23 cl, 6 dwg, 8 tbl, 4 ex
Authors
Dates
2014-09-10—Published
2009-07-01—Filed